1. CTIM-15. FIRST-IN-HUMAN PHASE 1 STUDY OF CD200 ACTIVATION RECEPTOR-LIGAND (CD200AR-L) AND ALLOGENEIC TUMOR LYSATE VACCINE IMMUNOTHERAPY FOR RECURRENT GLIOBLASTOMA: INITIAL RESULTS FROM AN ONGOING CLINICAL TRIAL. (12th November 2021) Authors: Neil, Elizabeth; Eaton, Anne; Lunn, Shannon; Nelson, Kristen; Greengard, Emily; Moertel, Christopher; Olin, Michael Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTIM-31. USE OF A SINGLE PEPTIDE CHECKPOINT INHIBITOR FOR TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS. (9th November 2020) Authors: Moertel, Christopher; Xiong, Zhengming; Zellmer, David; Pluhar, Elizabeth; Neil, Elizabeth; Greengard, Emely; Olin, Michael Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. INNV-25. RITUXIMAB MONOTHERAPY FOR TREATMENT OF RARE LOW GRADE PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; A CASE REPORT AND LITERATURE REVIEW. (12th November 2021) Authors: Tobin, Grace; Neil, Elizabeth Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. RADT-15. FIRST EXPERIENCE WITH MAXIMAL SAFE RESECTION AND GAMMATILE BRACHYTHERAPY AS TREATMENT FOR RECURRENT GLIOBLASTOMA. (12th November 2021) Authors: Gessler, Dominic; Neil, Elizabeth; Shah, Rena; Levine, Joseph; Shanks, James; Wilke, Christopher; Reynolds, Margaret; Ferreira, Clara; Dusenbery, Kathryn; Chen, Clark Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗